Ignite Creation Date:
2024-05-06 @ 2:42 PM
Last Modification Date:
2024-10-26 @ 1:36 PM
Study NCT ID:
NCT04409236
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-08
First Post:
2020-05-26
Brief Title:
Quit2Heal Smartphone App in Helping Cancer Patients Quit Smoking
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Fred Hutchinson Cancer Center
Study Overview
Official Title:
Randomized Trial of a Smartphone Application to Help Cancer Patients Stop Smoking Quit2Heal
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This phase III trial compares the Quit2Heal smoking cessation smartphone application app to the QuitGuide app in helping cancer patients quit smoking Both apps provide tools to cope with urges to smoke step-by-step guides for quitting smoking help in planning for quitting and staying tobacco-free and scientifically-based recommendations for how to select medications that aid in smoking cessation
Detailed Description:
OUTLINE Patients are randomized to 1 of 2 arms
ARM I Patients receive the Quit2Heal app and are encouraged to use it frequently During the entire 12-month follow-up period the app will remain fully available anytime study participants wish to use it
ARM II Patients receive the QuitGuide app and are encouraged to use it frequently During the entire 12-month follow-up period the app will remain fully available anytime study participants wish to use it
After randomization patients are followed up at 3 6 and 12 months
ARM I Patients receive the Quit2Heal app and are encouraged to use it frequently During the entire 12-month follow-up period the app will remain fully available anytime study participants wish to use it
ARM II Patients receive the QuitGuide app and are encouraged to use it frequently During the entire 12-month follow-up period the app will remain fully available anytime study participants wish to use it
After randomization patients are followed up at 3 6 and 12 months
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01CA253975 | NIH | Fred HutchUniversity of Washington Cancer Consortium | httpsreporternihgovquickSearchR01CA253975 |
| NCI-2020-03442 | OTHER_GRANT | None | None |
| 10432 | OTHER | None | None |